Activity value 76International Buyer&Supplier,Last transaction date:
2026-02-16
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for ariel pharmaceutical ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 9 transactions, with a transaction quantity of 777 and a transaction weight of 0.
YearTransactionsQuantityWeight
20251414115930
202697770
Bill of lading data
<
1/15
>
Trade date
2026/01/12
B/L No.
0071718
Suppliers
jb multi traders
Buyers
ariel pharmaceutical ltd.
POLs
chennai (ex madras)
PODs
port moresby
Supply area
India
Purchas area
Papua New Guinea
Weight
——
Amount
71324.52
Hs code
90183990
Product tags
non absorbable,adva,oct,surgical suture
Product description
ADVA 3328 12S3 0 70CM ADVA3328 2 METRICNON ABSORBABLE SURGICAL SUTURE U S P BA NO V257136 MF NOV 25 EXP OCT 30
Expand
Trade date
2026/01/12
B/L No.
5575331
Suppliers
jb multi traders
Buyers
ariel pharmaceutical ltd.
ariel pharmaceutical ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as medicine,surgical,bat.
According to the 52wmb.com global trade database, as of 2026-02-16, the company has completed 2294 international trades,
with its main trading regions covering india,pakistan,other etc.
The core products include HS30049099,HS90183990,HS90189099 etc,
often transported via port moresby,port moresby etc,
and its main trading partners are jb multi traders,haji suleman adam kothari co,d3prime pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on ariel pharmaceutical ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.